Dopaminergic agonist with opposing effects on dopamine. Avoid concomitant use to prevent exacerbation of parkinsonian symptoms.
Source: NLP:metoclopramide
8 interactions on record
Dopaminergic agonist with opposing effects on dopamine. Avoid concomitant use to prevent exacerbation of parkinsonian symptoms.
Source: NLP:metoclopramide
Dopaminergic agonist with opposing effects on dopamine; potential exacerbation of symptoms. Avoid concomitant use.
Source: NLP:metoclopramide hydrochloride
Increases cyclosporine concentrations. Dosage adjustment essential.
Source: NLP:cyclosporine
Concomitant administration may increase the absorption of bromocriptine.
Source: NLP:lanreotide acetate
Concomitant administration of octreotide and bromocriptine increases the availability of bromocriptine.
Source: NLP:octreotide acetate
Weak/moderate CYP3A4/P-gp inhibitor that may increase sirolimus concentrations. Monitor and adjust dosage as needed.
Source: NLP:sirolimus
Concomitant bromocriptine therapy elevates serum tamoxifen and N-desmethyl tamoxifen concentrations.
Source: NLP:tamoxifen citrate
Not recommended for concomitant use; hypotensive effects may be cumulative.
Source: NLP:tizanidine hydrochloride